CLEC16A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62925228863742E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
3.21019877347339E-11 |
Normal-vs-Stage3 |
1.62814206561279E-12 |
Normal-vs-Stage4 |
1.62769797640294E-12 |
Stage1-vs-Stage2 |
3.528400E-01 |
Stage1-vs-Stage3 |
1.837390E-01 |
Stage1-vs-Stage4 |
1.134640E-01 |
Stage2-vs-Stage3 |
9.588000E-01 |
Stage2-vs-Stage4 |
7.302000E-01 |
Stage3-vs-Stage4 |
5.937600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.99200722162641E-16 |
Normal-vs-AfricanAmerican |
4.88009999999317E-06 |
Normal-vs-Asian |
4.986400E-02 |
Caucasian-vs-AfricanAmerican |
6.257900E-03 |
Caucasian-vs-Asian |
9.404200E-02 |
AfricanAmerican-vs-Asian |
8.020000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.09134923320653E-13 |
Male-vs-Female |
2.647400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.28350000003519E-06 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.46370027209741E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.201200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.313800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.597850E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.019800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.858180E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.009600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.449600E-04 |
Normal-vs-Grade 2 |
4.9960036108132E-15 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
2.83983947468869E-12 |
Grade 1-vs-Grade 2 |
4.072200E-01 |
Grade 1-vs-Grade 3 |
3.833800E-01 |
Grade 1-vs-Grade 4 |
5.886600E-01 |
Grade 2-vs-Grade 3 |
8.209200E-01 |
Grade 2-vs-Grade 4 |
5.247600E-01 |
Grade 3-vs-Grade 4 |
4.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.55170000182281E-08 |
ccA subtype-vs-ccB subtype |
6.43499697972061E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.99200722162641E-15 |
Normal-vs-N1 |
1.320540E-03 |
N0-vs-N1 |
1.664440E-01 |
|
|